GlaxoSmithKline (GSK)

Add to Watchlists
Create an Alert
45.79 +0.43  +0.95% NYSE Oct 24, 8:00PM BATS Real time Currency in USD

GlaxoSmithKline Total Liabilities (Quarterly):

57.26B for Sept. 30, 2014

View 4,000+ financial data types

View Full Chart

GlaxoSmithKline Total Liabilities (Quarterly) Chart

Export Data
Save Image

GlaxoSmithKline Historical Total Liabilities (Quarterly) Data

View and export this data going back to 1986. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Sept. 30, 2014 57.26B
June 30, 2014 55.74B
March 31, 2014 55.02B
Dec. 31, 2013 57.86B
Sept. 30, 2013 56.58B
June 30, 2013 54.39B
March 31, 2013 55.01B
Dec. 31, 2012 57.59B
Sept. 30, 2012 55.57B
June 30, 2012 54.94B
March 31, 2012 51.11B
Dec. 31, 2011 50.95B
Sept. 30, 2011 52.95B
June 30, 2011 53.54B
March 31, 2011 53.75B
Dec. 31, 2010 51.58B
Sept. 30, 2010 51.88B
June 30, 2010 51.42B
March 31, 2010 51.27B
Dec. 31, 2009 52.99B
Sept. 30, 2009 51.42B
June 30, 2009 46.65B
March 31, 2009 44.47B
Dec. 31, 2008 45.81B
Sept. 30, 2008 47.25B
   
June 30, 2008 50.10B
March 31, 2008 42.62B
Dec. 31, 2007 42.68B
Sept. 30, 2007 36.33B
June 30, 2007 32.19B
March 31, 2007 32.22B
Dec. 31, 2006 31.66B
Sept. 30, 2006 31.23B
June 30, 2006 32.50B
March 31, 2006 33.35B
Dec. 31, 2005 34.21B
Sept. 30, 2005 33.14B
June 30, 2005 32.94B
March 31, 2005 32.82B
Dec. 31, 2004 32.22B
Sept. 30, 2004 29.09B
June 30, 2004 29.36B
March 31, 2004 28.20B
Dec. 31, 2003 28.95B
Sept. 30, 2003 27.30B
June 30, 2003 26.28B
March 31, 2003 24.25B
Dec. 31, 2002 25.33B
Sept. 30, 2002 23.82B
June 30, 2002 24.14B

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Total Liabilities

Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.

Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.

Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.

Simply, liabilities are the part of a company's assets that it has yet to repay back.
Learn More

Get data for
Advertisement

GSK Total Liabilities (Quarterly) Benchmarks

Companies
AstraZeneca 36.51B
Pfizer 95.98B
Johnson & Johnson 57.15B

GSK Total Liabilities (Quarterly) Range, Past 5 Years

Minimum 50.95B Dec 2011
Maximum 57.86B Dec 2013
Average 54.07B

GSK Total Liabilities (Quarterly) Excel Add-In Codes

  • Metric Code: liabilities
  • Latest data point: =YCP("GSK", "liabilities")
  • Last 5 data points: =YCS("GSK", "liabilities", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.